---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289957464.md"
description: "ESAB shares are trading higher after DA Davidson initiated its coverage on the stock with a Buy rating and announced a price target of $130."
datetime: "2026-06-16T17:11:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289957464.md)
  - [en](https://longbridge.com/en/news/289957464.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289957464.md)
generator: "portal-rs"
---

# 

ESAB shares are trading higher after DA Davidson initiated its coverage on the stock with a Buy rating and announced a price target of $130.

### Related Stocks

- [ESAB.US](https://longbridge.com/en/quote/ESAB.US.md)

## Related News & Research

- [ESAB Corporation (NYSE:ESAB) Given Consensus Recommendation of "Moderate Buy" by Brokerages](https://longbridge.com/en/news/295634233.md)
- [ESAB director Rhonda L. Jordan disposes of 1,000 common shares worth $95,000](https://longbridge.com/en/news/295446996.md)
- [Diamondback Energy, Inc. $FANG Position Increased by Continuum Advisory LLC](https://longbridge.com/en/news/298008402.md)
- [OMU: Life APE sales up 21%, return on group equity value at 12.7%, and interim dividend up 8%](https://longbridge.com/en/news/298266160.md)
- [Aptar and Aceso Therapeutics Announce Collaboration to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis](https://longbridge.com/en/news/298212506.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**